Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
Sonnet, Pascal
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide. [electronic resource] - International journal of antimicrobial agents Jan 2012 - 77-80 p. digital
Publication Type: Journal Article
1872-7913
10.1016/j.ijantimicag.2011.08.005 doi
Anti-Bacterial Agents--pharmacology
Ciprofloxacin--pharmacology
Dipeptides--pharmacology
Drug Resistance, Multiple, Bacterial--drug effects
Fluoroquinolones--pharmacology
Humans
Levofloxacin
Membrane Transport Proteins--metabolism
Microbial Sensitivity Tests
Ofloxacin--pharmacology
Piperazine
Piperazines--pharmacology
Prevalence
Pseudomonas Infections--epidemiology
Pseudomonas aeruginosa--drug effects
Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide. [electronic resource] - International journal of antimicrobial agents Jan 2012 - 77-80 p. digital
Publication Type: Journal Article
1872-7913
10.1016/j.ijantimicag.2011.08.005 doi
Anti-Bacterial Agents--pharmacology
Ciprofloxacin--pharmacology
Dipeptides--pharmacology
Drug Resistance, Multiple, Bacterial--drug effects
Fluoroquinolones--pharmacology
Humans
Levofloxacin
Membrane Transport Proteins--metabolism
Microbial Sensitivity Tests
Ofloxacin--pharmacology
Piperazine
Piperazines--pharmacology
Prevalence
Pseudomonas Infections--epidemiology
Pseudomonas aeruginosa--drug effects